Diabetes treatment lowers PromarkerD risk score: Results presented at Australasian Diabetes Congress
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to...
Related posts
The Company has successfully produced a pilot batch of PromarkerD test components with specialist...
Proteomics International, the leader in predictive diagnostics for diabetic kidney disease,...